Pulse Biosciences (PLSE) had the highest return between January 17, 2017 and March 30, 2017 by a small-cap US stock, returning 326.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Pulse Biosciences (PLSE) | 1/17/2017 - 3/30/2017 | 326.86% |
Esperion Therapeutics (ESPR) | 1/17/2017 - 3/30/2017 | 194.7% |
Aurinia Pharmaceuticals (AUPH) | 1/17/2017 - 3/30/2017 | 193.31% |
Aehr Test Systems (AEHR) | 1/17/2017 - 3/30/2017 | 111.33% |
LifeMD (LFMD) | 1/17/2017 - 3/30/2017 | 96.15% |
Applied Opt (AAOI) | 1/17/2017 - 3/30/2017 | 91.59% |
Verastem (VSTM) | 1/17/2017 - 3/30/2017 | 88.89% |
Microvision (MVIS) | 1/17/2017 - 3/30/2017 | 85.5% |
Nektar Therapeutics (NKTR) | 1/17/2017 - 3/30/2017 | 81.92% |
AnaptysBio (ANAB) | 1/17/2017 - 3/30/2017 | 79.88% |
Syndax Pharmaceuticals (SNDX) | 1/17/2017 - 3/30/2017 | 78.39% |
TSS, Inc Common Stock (TSSI) | 1/17/2017 - 3/30/2017 | 78% |
Gravity (GRVY) | 1/17/2017 - 3/30/2017 | 75% |
Assembly Biosciences (ASMB) | 1/17/2017 - 3/30/2017 | 72.99% |
Safe Bulkers (SB) | 1/17/2017 - 3/30/2017 | 70.58% |
Clearpoint Neuro (CLPT) | 1/17/2017 - 3/30/2017 | 66.67% |
Maui Land & Pineapple (MLP) | 1/17/2017 - 3/30/2017 | 63.96% |
Harrow Health (HROW) | 1/17/2017 - 3/30/2017 | 63.57% |
Hello (MOMO) | 1/17/2017 - 3/30/2017 | 63.09% |
DiaMedica Therapeutics (DMAC) | 1/17/2017 - 3/30/2017 | 63.08% |
Golden Ocean (GOGL) | 1/17/2017 - 3/30/2017 | 58.05% |
Himax Technologies (HIMX) | 1/17/2017 - 3/30/2017 | 51.48% |
Cronos (CRON) | 1/17/2017 - 3/30/2017 | 50.11% |
Semler Scientific (SMLR) | 1/17/2017 - 3/30/2017 | 49.83% |
Tronox (TROX) | 1/17/2017 - 3/30/2017 | 49.12% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
